Speech Intelligibility in Quiet and Noise for New vs. Legacy Hearing Aids
NCT ID: NCT05101083
Last Updated: 2022-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2021-10-25
2022-01-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Hearing Aid Benefit
NCT05198713
Self Fitting Hearing Aid Clinical Investigation
NCT05612763
A Comparison of Hearing Aid Noise Programs on Speech Intelligibility
NCT06957730
Benefits of Assistive Listening Device for Speech Intelligibility
NCT05072470
Evaluation of In-lab Benefit for Speech-in-noise Intelligibility With Device for Adults With Mild to Moderate Hearing Loss
NCT07074769
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hearing Aid 1
New Receiver-in-Canal device, successor of previous device generation
Legacy Receiver-in-Canal Device
Receiver-in-canal device available on the market
Hearing Aid 2
Legacy Receiver-in-Canal device that is currently available on the market
New Receiver-in-Canal Device
Successor of previous device generation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
New Receiver-in-Canal Device
Successor of previous device generation
Legacy Receiver-in-Canal Device
Receiver-in-canal device available on the market
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Native English speakers
* Ability to complete questionnaires and laboratory assessments
* Symmetric, mild to moderately-severe sensorineural hearing loss
* Informed consent completed with signature
Exclusion Criteria
* Central or middle ear hearing problems
* Medical contraindications to wearing hearing aids
* Learning disability, major cognitive handicap, or serious neurological or psychiatric disease that would prevent or restrict participation, as determined by the PI or designee
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Starkey Laboratories, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Starkey
Eden Prairie, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PR 21001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.